Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique最新文献

{"title":"TDM et IRM dans les cancers du col inopérables","authors":"D Buthiau , E Antoine , D Nizri , N Renody , D Dargent , D Khayat","doi":"10.1016/S0924-4212(97)86110-5","DOIUrl":"10.1016/S0924-4212(97)86110-5","url":null,"abstract":"","PeriodicalId":79321,"journal":{"name":"Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique","volume":"83 4","pages":"Page 390"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0924-4212(97)86110-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56283758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacité du strontium 89 dans le traitement palliatif de la douleur liée aux métastases osseuses du cancer de prostate (KP)","authors":"B Georges, C Durdux, C Hennequin, F Desgrandchamps, JD Rain, M Housset, MC Douard, A Leduc, C Maylin","doi":"10.1016/S0924-4212(97)86079-3","DOIUrl":"10.1016/S0924-4212(97)86079-3","url":null,"abstract":"","PeriodicalId":79321,"journal":{"name":"Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique","volume":"83 4","pages":"Pages 306-307"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0924-4212(97)86079-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56283480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiothérapie hyperfractionnée et accélérée dans les cancers de la tête et du cou: résultats des essais de l'EORTC et impact sur la pratique clinique","authors":"JC Horiot , P Bontemps , AC Begg , R Le Fur , W Van den Bogaert , M Bolla , T N'Guyen , D Van den Weijngaert , J Bernier , A Lusinchi , D Stuschke , D Lopez Torrecilla , B Jancar , L Collette , M Van Glabbeke , M Pierart","doi":"10.1016/S0924-4212(97)86083-5","DOIUrl":"10.1016/S0924-4212(97)86083-5","url":null,"abstract":"","PeriodicalId":79321,"journal":{"name":"Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique","volume":"83 4","pages":"Pages 314-320"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0924-4212(97)86083-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56283505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Existe-t-il encore une place pour la radiothérapie dans le traitement des lymphomes non hodgkiniens?","authors":"C Hennequin , JM Cosset","doi":"10.1016/S0924-4212(97)86064-1","DOIUrl":"10.1016/S0924-4212(97)86064-1","url":null,"abstract":"","PeriodicalId":79321,"journal":{"name":"Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique","volume":"83 4","pages":"Pages 269-272"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0924-4212(97)86064-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56283189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"P3 Place de la radiothérapie dans les lymphomes non hodgkiniens à cellules du manteau: étude rétrospective de 23 patients traités à l'institut Gustave-Roussy","authors":"F Dhermain, K Gosset, D Decaudin, JN Munck, JL Pico, P Carde, J Bosq, M Hayat, R Arriagada","doi":"10.1016/S0924-4212(97)86067-7","DOIUrl":"10.1016/S0924-4212(97)86067-7","url":null,"abstract":"","PeriodicalId":79321,"journal":{"name":"Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique","volume":"83 4","pages":"Pages 273-274"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0924-4212(97)86067-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56283224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"P38 Étude multiparamétrique in vitro d'une association radiochimiothérapie","authors":"J. Balosso, V. Favaudon, Hl Liber, J. Little","doi":"10.1016/S0924-4212(97)86157-9","DOIUrl":"https://doi.org/10.1016/S0924-4212(97)86157-9","url":null,"abstract":"","PeriodicalId":79321,"journal":{"name":"Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique","volume":"83 1","pages":"432"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0924-4212(97)86157-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56284232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"P42 Adamantimome de l'extrémité inférieure du tibia: une observation","authors":"V. Favrel, T. Schmitt, G. Bousquet, P. Casini, J. Mosnier","doi":"10.1016/S0924-4212(97)86161-0","DOIUrl":"https://doi.org/10.1016/S0924-4212(97)86161-0","url":null,"abstract":"","PeriodicalId":79321,"journal":{"name":"Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique","volume":"10 1","pages":"433-434"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0924-4212(97)86161-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56284261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Neutrontherapy in soft tissue sarcomas: a review of European results","authors":"R. Schwarz ,&nbsp;A. Krüll ,&nbsp;M. Steingräber ,&nbsp;A. Lessel ,&nbsp;R. Engenhart ,&nbsp;A. Favre ,&nbsp;N. Breteau ,&nbsp;F.J. Prott ,&nbsp;T. Auberger ,&nbsp;R. Schmidt","doi":"10.1016/0924-4212(96)84894-8","DOIUrl":"10.1016/0924-4212(96)84894-8","url":null,"abstract":"<div><p>The purpose of this publication is to review the data on European neutrontherapy facilities in the treatment of soft tissue sarcoma. Data on 1171 patients treated at 11 centers were analyzed. Neutrontherapy was of advantage especially for patients with primary radiotherapy of inoperable tumors, and those with macroscopic disease after surgery. Local control was about 50% in these groups. Results for postoperative neutrontherapy after R0 and R1 resection were similiar to those for photon therapy. The incidence of late side effects was considerable. This was influenced by the fact that most patients were treated with first-generation machines.</p></div><div><p>Les dossiers de 1171 patients traités dans 11 hôpitaux européens sont analysés. La neutronthérapie présente des avantages pour les patients porteurs de tumeurs inopérables ou de reliquats macroscopiques. La probabilité de contrôle local est d’environ 50% dans ces groupes. Pour les patients R0 ou R1, les résultats de la neutronthérapie sont équivalent à ceux obtenus par rayons X. La morbidité est importante dans certaines séries où la majorité des patients ont été irradiés avec des machines de la première génération.</p></div>","PeriodicalId":79321,"journal":{"name":"Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique","volume":"83 ","pages":"Pages 110s-114s"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0924-4212(96)84894-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19912232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Calculation of RBE for normal tissue complications based on charged particle track structure","authors":"M. Scholz","doi":"10.1016/0924-4212(96)84885-7","DOIUrl":"10.1016/0924-4212(96)84885-7","url":null,"abstract":"<div><p>A new approach for the calculation of relative biological effectiveness (RBE) for normal tissue complications after charged particle and neutron irradiation is discussed. It is based on the extension of a model originally developed for the application to cell survival. It can be shown that according to the model RBE values are determined largely by the α/β-ratio of the photon dose response curve, but are expected to be nearly independent of the absolute values of α and β<em>.</em> Thus the model can be applied to normal tissue complications as well, where α/β<em>-</em> ratios can be determined by means of fractionation experiments. Agreement of model predictions and experimental results obtained in animal experiments confirm the applicabilité of the model even in the case of complex biological endpoints.</p></div><div><p>Nous proposons dans ce travail une approche nouvelle d’évaluation de l’efficacité biologique relative (EBR) pour les tissus sains après irradiation par neutrons ou par des faisceaux de particules chargées. Il s’agit en réalité de l’extension d’un modèle développé initialement pour décrire la survie cellulaire. Dans ce modèle, les valeurs d’EBR sont essentiellement déterminées par le quotient alpha/beta dérivé des courbes de réponse en fonction de la dose photon. Les résultats attendus sont cependant presque indépendants des valeurs absolues de alpha et beta. Ce modèle peut par conséquent être utilisé pour évaluer la réponse des tissus sains en calculant le rapport alpha/beta à l’aide des valeurs moyennes obtenues à partir des données expérimentales recueillies avec les irradiations fractionnées. La concordance entre les résultats expérimentaux sur l’animal et les résultats attendus par le calcul confirment la valeur du modèle même dans les cas biologiques complexes.</p></div>","PeriodicalId":79321,"journal":{"name":"Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique","volume":"83 ","pages":"Pages 50s-54s"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0924-4212(96)84885-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19912725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The neutron therapy clinical programme at the National Accelerator Centre (NAC)","authors":"C.E. Stannard ,&nbsp;F.J. Vernimmen ,&nbsp;D.T.L. Jones ,&nbsp;A.L. Van Wijk ,&nbsp;S.M. Brennan ,&nbsp;A.M. Visser ,&nbsp;C.A. Johnson ,&nbsp;J.A.G. Wilson ,&nbsp;E.A. Murray ,&nbsp;C.V. Levin ,&nbsp;E.E.D. Mills ,&nbsp;A. Alberts ,&nbsp;I.D. Werner ,&nbsp;B.J. Smit ,&nbsp;G. Schmitt","doi":"10.1016/0924-4212(96)84890-0","DOIUrl":"10.1016/0924-4212(96)84890-0","url":null,"abstract":"<div><p>A total of 721 patients were treated in the neutron therapy programme at NAC from February 1989-March 1995 with a p(66)/Be isocentric unit. The preliminary results showed: 3-year local control and survival probabilities of 57 and 79% respectively for advanced salivary gland tumours; increased local control for twice-daily neutron therapy for advanced head and neck cancer compared with photon therapy; local control rates of 68 and 83% for locally advanced breast cancer treated with 17 and 19 Gy respectively; complete response rates of 67% for macroscopic residual soft tissue sarcomas and those with irresectable disease of less than 10 cm; complete response rate of 56% for macroscopic residual uterine sarcoma with a median follow up of 38 months; 2-year local control rate and survival of 44 and 38% respectively for advanced squamous carcinoma of the maxillary antrum; complete response rate of 38% for advanced osteosarcomas and chondrosarcomas.</p></div><div><p>De février 1989 à mars 1995, 721 patients ont été traités au NAC avec un faisceau de neutrons produits par la réaction p(66)Be et une tête de traitement isocentrique. Les résultats préliminaires sont les suivants : pour les tumeurs des glandes salivaires, le contrôle local et la survie sont respectivement 57 et 79% à 3 ans; pour les cancers avancés de la tête et du cou, un essai prospectif randomisé comparant un traitement par photons à un traitement bifractionné par neutrons, met en évidence un bénéfice statistiquement significatif en termes de contrôle local en faveur du bras neutron; pour les cancers du sein localement évolués, le contrôle local est respectivement de 68 et 83% pour des doses de 17 et 19 Gy n<!--> <!-->+<!--> <!-->γ; pour les sarcomes des tissus mous, une réponse complète est obtenue dans 67% des cas pour des tumeurs en résection insuffisante ou en place &lt;10<!--> <!-->cm; pour les sarcomes utérins en résection insuffisante ou en récidive (&lt;<!--> <!-->7<!--> <!-->cm), le contrôle local est de 56% pour un suivi médian de 38 mois; pour les cancers inopérables du massif facial, le contrôle local et la survie à 2 ans, sont respectivement 44 et 38%.</p></div>","PeriodicalId":79321,"journal":{"name":"Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique","volume":"83 ","pages":"Pages 87s-92s"},"PeriodicalIF":0.0,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0924-4212(96)84890-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19912730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}